Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

Point Of Care ◽

Controlled Trial ◽

Clinical Impact ◽

Open Label ◽

Test And Treat ◽

Point Of Care Test ◽

Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(98)12494-7 ◽

1999 ◽

Vol 354 (9173) ◽

pp. 106-110 ◽

Cited By ~ 99

Author(s):

George J Despotis ◽

Vladimir Levine ◽

Rao Saleem ◽

Edward Spitznagel ◽

J Heinrich Joist

Keyword(s):

Cardiac Surgery ◽

Point Of Care ◽

Controlled Trial ◽

Point Of Care Test ◽

Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial

The Lancet HIV ◽

10.1016/s2352-3018(19)30402-3 ◽

2020 ◽

Vol 7 (4) ◽

pp. e229-e237 ◽

Cited By ~ 13

Author(s):

Paul K Drain ◽

Jienchi Dorward ◽

Lauren R Violette ◽

Justice Quame-Amaglo ◽

Katherine K Thomas ◽

...

Keyword(s):

Viral Load ◽

Point Of Care ◽

Controlled Trial ◽

Task Shifting ◽

Load Testing ◽

Hiv Viral Load ◽

Open Label ◽

Improve Treatment ◽

Faculty Opinions recommendation of Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726215273.793517918 ◽

2016 ◽

Author(s):

Anthony Harries

Keyword(s):

Treatment Initiation ◽

Point Of Care ◽

Controlled Trial ◽

Tuberculosis Treatment ◽

Hiv Positive ◽

Open Label ◽

Parallel Group ◽

Randomised Controlled ◽

Hospital Inpatients

Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial

The Lancet Global Health ◽

10.1016/s2214-109x(18)30444-3 ◽

2019 ◽

Vol 7 (1) ◽

pp. e119-e131 ◽

Cited By ~ 20

Author(s):

Thomas Althaus ◽

Rachel C Greer ◽

Myo Maung Maung Swe ◽

Joshua Cohen ◽

Ni Ni Tun ◽

...

Keyword(s):

Primary Care ◽

Antibiotic Prescription ◽

Point Of Care ◽

Controlled Trial ◽

C Reactive Protein ◽

Open Label ◽

Reactive Protein ◽

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(15)01092-2 ◽

2016 ◽

Vol 387 (10024) ◽

pp. 1187-1197 ◽

Cited By ~ 129

Author(s):

Jonny G Peter ◽

Lynn S Zijenah ◽

Duncan Chanda ◽

Petra Clowes ◽

Maia Lesosky ◽

...

Keyword(s):

Treatment Initiation ◽

Point Of Care ◽

Controlled Trial ◽

Tuberculosis Treatment ◽

Hiv Positive ◽

Open Label ◽

Parallel Group ◽

Randomised Controlled ◽

Hospital Inpatients

Effect of incorporating a 10 minute point of care test for salivary nicotine metabolites into a general practice based smoking cessation programme: randomised controlled trial

BMJ ◽

10.1136/bmj.38621.463900.7c ◽

2005 ◽

Vol 331 (7523) ◽

pp. 999 ◽

Cited By ~ 35

Author(s):

Kristian D Barnfather ◽

Graham F Cope ◽

Iain L Chapple

Keyword(s):

General Practice ◽

Smoking Cessation ◽

Point Of Care ◽

Controlled Trial ◽

Smoking Cessation Programme ◽

Point Of Care Test ◽

Minute Point ◽

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(17)30120-0 ◽

2017 ◽

Vol 5 (5) ◽

pp. 401-411 ◽

Cited By ~ 129

Author(s):

Nathan J Brendish ◽

Ahalya K Malachira ◽

Lawrence Armstrong ◽

Rebecca Houghton ◽

Sandra Aitken ◽

...

Keyword(s):

Point Of Care ◽

Controlled Trial ◽

Respiratory Illness ◽

Respiratory Viruses ◽

Acute Respiratory Illness ◽

Point Of Care Testing ◽

Open Label ◽

Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166102.628092 ◽

2009 ◽

Author(s):

Jim Orr ◽

Fadi Abu Shahin

Keyword(s):

Ovarian Cancer ◽

Controlled Trial ◽

Advanced Ovarian Cancer ◽

Open Label ◽

Phase 3 ◽

Dose Dense ◽

Faculty Opinions recommendation of Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12032956.13172054 ◽

2011 ◽

Author(s):

Carlos Seas ◽

Jorge Alave

Keyword(s):

Enteric Fever ◽

Controlled Trial ◽

Open Label ◽

Faculty Opinions recommendation of Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13368964.14739064 ◽

2011 ◽

Author(s):

Vineet Bhandari

Keyword(s):

Mechanical Ventilation ◽

Preterm Infants ◽

Controlled Trial ◽

Open Label ◽

Surfactant Treatment ◽

Randomised Controlled ◽

Spontaneously Breathing